A phase III randomised controlled trial of erlotinib vs gefitinib in advanced non-small cell lung cancer with EGFR mutations
収録刊行物
-
- British Journal of Cancer
-
British Journal of Cancer 116 (5), 568-574, 2017-01-19
Springer Science and Business Media LLC